Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Sep;33(3):499–502.

The effect of levamisole on E-rosette formation by trypsinized lymphocytes.

R Lomnitzer, A R Rabson
PMCID: PMC1537449  PMID: 310743

Abstract

Normal lymphocytes treated with trypsin lost their ability to form normal numbers of rosettes with sheep red blood cells. The recovery in E-rosette forming capacity of trypsinized cells was considerably augmented when the cells were incubated in the presence of a wide range of concentrations of the immunostimulatory drug, levamisole. Substantial recovery of rosette-forming ability was seen 2 hr after incubation of trypsinized cells with levamisole.

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chisari F. V., Routenberg J. A., Edgington T. S. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. J Clin Invest. 1976 May;57(5):1227–1238. doi: 10.1172/JCI108391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gattringer C., Wick G. Relationship between E receptors and a T-specific surface antigen on human T cells. Immunology. 1977 Feb;32(2):199–205. [PMC free article] [PubMed] [Google Scholar]
  3. Grieco M. H., Siegel I., Goel Z. Modulation of human T lymphocyte rosette formation by autonomic agonists and cyclic nucleotides. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 2):149–159. doi: 10.1016/0091-6749(76)90150-0. [DOI] [PubMed] [Google Scholar]
  4. Hadden J. W., Coffey R. G., Hadden E. M., Lopez-Corrales E., Sunshine G. H. Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. Cell Immunol. 1975 Nov;20(1):98–103. doi: 10.1016/0008-8749(75)90088-x. [DOI] [PubMed] [Google Scholar]
  5. Lieberman R., Hsu M. Levamisole-mediated restoration of cellular immunity in peripheral blood lymphocytes of patients with immunodeficiency diseases. Clin Immunol Immunopathol. 1976 Jan;5(1):142–146. doi: 10.1016/0090-1229(76)90157-4. [DOI] [PubMed] [Google Scholar]
  6. Moncada-González B., Rodriguez-Escobedo M. L., Castanedo de Alba J. P. Letter: Effect of levamisole on E rosettes. N Engl J Med. 1976 Jul 22;295(4):230–230. doi: 10.1056/NEJM197607222950422. [DOI] [PubMed] [Google Scholar]
  7. Ramot B., Biniaminov M., Shoham C., Rosenthal E. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med. 1976 Apr 8;294(15):809–811. doi: 10.1056/NEJM197604082941504. [DOI] [PubMed] [Google Scholar]
  8. Rosenthal M. Levamisole increases activated T lymphocytes. Lancet. 1977 Sep 24;2(8039):665–665. doi: 10.1016/s0140-6736(77)92538-7. [DOI] [PubMed] [Google Scholar]
  9. Scheinberg M., Blacklow N. R., Goldstein A. L., Parrino T. A., Rose F. B., Cathcart E. S. Influenza: response of T-cell lymphopenia to thymosin. N Engl J Med. 1976 May 27;294(22):1208–1211. doi: 10.1056/NEJM197605272942204. [DOI] [PubMed] [Google Scholar]
  10. Schmidt M. E., Douglas S. D. Effects of levamisole on human monocyte function and immunoprotein receptors. Clin Immunol Immunopathol. 1976 Nov;6(3):299–305. doi: 10.1016/0090-1229(76)90082-9. [DOI] [PubMed] [Google Scholar]
  11. Symoens J., Rosenthal M. Levamisole in the modulation of the immune response: the current experimental and clinical state. J Reticuloendothel Soc. 1977 Mar;21(3):175–221. [PubMed] [Google Scholar]
  12. Thomas H. C., Freni M., Sanchez-Tapias J., de Villiers D., Jain S., Sherlock S. Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol. 1976 Nov;26(2):222–227. [PMC free article] [PubMed] [Google Scholar]
  13. Verhaegen H., De Cock W., De Cree J. The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients. Clin Exp Immunol. 1977 Aug;29(2):311–315. [PMC free article] [PubMed] [Google Scholar]
  14. Whitcomb M. E., Merluzzi V. J., Cooperband S. R. The effect of levamisole on human lymphocyte mediator production in vitro. Cell Immunol. 1976 Feb;21(2):272–277. doi: 10.1016/0008-8749(76)90056-3. [DOI] [PubMed] [Google Scholar]
  15. Wybran J., Govaerts A. Levamisole and human lymphocyte surface markers. Clin Exp Immunol. 1977 Feb;27(2):319–321. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES